Panoquell-CA1 is an FDA conditionally approved innovative solution for acute canine pancreatitis (ACP).

Panoquell-CA1 inhibits the infiltration of neutrophilic inflammation within the pancreas that occurs in ACP and is fast and effective at by significantly reducing associated signs.

Intravenous injection dosed once a day for 3 days. A multi-use vial that once reconstituted remains stable for 28 days refrigerated.

Dehydration is a common symptom of gastrointestinal issues such as pancreatitis. Check out the Dehydration Wheel to assist in resolving it